Potential therapeutic role of pyroptosis mediated by the NLRP3 inflammasome in type 2 diabetes and its complications
- PMID: 36387904
- PMCID: PMC9646639
- DOI: 10.3389/fendo.2022.986565
Potential therapeutic role of pyroptosis mediated by the NLRP3 inflammasome in type 2 diabetes and its complications
Abstract
As a new way of programmed cell death, pyroptosis plays a vital role in many diseases. In recent years, the relationship between pyroptosis and type 2 diabetes (T2D) has received increasing attention. Although the current treatment options for T2D are abundant, the occurrence and development of T2D appear to continue, and the poor prognosis and high mortality of patients with T2D remain a considerable burden in the global health system. Numerous studies have shown that pyroptosis mediated by the NLRP3 inflammasome can affect the progression of T2D and its complications; targeting the NLRP3 inflammasome has potential therapeutic effects. In this review, we described the molecular mechanism of pyroptosis more comprehensively, discussed the most updated progress of pyroptosis mediated by NLRP3 inflammasome in T2D and its complications, and listed some drugs and agents with potential anti-pyroptosis effects. Based on the available evidence, exploring more mechanisms of the NLRP3 inflammasome pathway may bring more options and benefits for preventing and treating T2D and drug development.
Keywords: NLRP3 inflammasome; complications; pyroptosis; therapy; type 2 diabetes.
Copyright © 2022 Li, Xiao, Guo, Song and Li.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures
Similar articles
-
PKM2-dependent glycolysis promotes skeletal muscle cell pyroptosis by activating the NLRP3 inflammasome in dermatomyositis/polymyositis.Rheumatology (Oxford). 2021 May 14;60(5):2177-2189. doi: 10.1093/rheumatology/keaa473. Rheumatology (Oxford). 2021. PMID: 33165604
-
A new research hot spot: The role of NLRP3 inflammasome activation, a key step in pyroptosis, in diabetes and diabetic complications.Life Sci. 2020 Jan 1;240:117138. doi: 10.1016/j.lfs.2019.117138. Epub 2019 Dec 4. Life Sci. 2020. PMID: 31809715 Review.
-
Harnessing pyroptosis for lung cancer therapy: The impact of NLRP3 inflammasome activation.Pathol Res Pract. 2024 Aug;260:155444. doi: 10.1016/j.prp.2024.155444. Epub 2024 Jul 1. Pathol Res Pract. 2024. PMID: 38986361 Review.
-
Modulatory Mechanisms of the NLRP3 Inflammasomes in Diabetes.Biomolecules. 2019 Dec 9;9(12):850. doi: 10.3390/biom9120850. Biomolecules. 2019. PMID: 31835423 Free PMC article. Review.
-
Targeting the NLRP3 inflammasome in diabetic retinopathy: From pathogenesis to therapeutic strategies.Biochem Pharmacol. 2023 Jun;212:115569. doi: 10.1016/j.bcp.2023.115569. Epub 2023 Apr 25. Biochem Pharmacol. 2023. PMID: 37100255 Review.
Cited by
-
The Mechanism of Pyroptosis and Its Application Prospect in Diabetic Wound Healing.J Inflamm Res. 2024 Mar 6;17:1481-1501. doi: 10.2147/JIR.S448693. eCollection 2024. J Inflamm Res. 2024. PMID: 38463193 Free PMC article. Review.
-
Pyroptosis in Diabetic Peripheral Neuropathy and its Therapeutic Regulation.J Inflamm Res. 2024 Jun 14;17:3839-3864. doi: 10.2147/JIR.S465203. eCollection 2024. J Inflamm Res. 2024. PMID: 38895141 Free PMC article. Review.
-
Mitochondria-associated programmed cell death as a therapeutic target for age-related disease.Exp Mol Med. 2023 Aug;55(8):1595-1619. doi: 10.1038/s12276-023-01046-5. Epub 2023 Aug 23. Exp Mol Med. 2023. PMID: 37612409 Free PMC article. Review.
-
Type 2 diabetes mellitus in adults: pathogenesis, prevention and therapy.Signal Transduct Target Ther. 2024 Oct 2;9(1):262. doi: 10.1038/s41392-024-01951-9. Signal Transduct Target Ther. 2024. PMID: 39353925 Free PMC article. Review.
-
Diabetic peripheral neuropathy based on Schwann cell injury: mechanisms of cell death regulation and therapeutic perspectives.Front Endocrinol (Lausanne). 2024 Aug 12;15:1427679. doi: 10.3389/fendo.2024.1427679. eCollection 2024. Front Endocrinol (Lausanne). 2024. PMID: 39193373 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials